KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Depreciation & Amortization (CF) (2017 - 2025)

Historic Depreciation & Amortization (CF) for Guardant Health (GH) over the last 9 years, with Q3 2025 value amounting to $9.4 million.

  • Guardant Health's Depreciation & Amortization (CF) fell 1122.85% to $9.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.1 million, marking a year-over-year decrease of 621.71%. This contributed to the annual value of $42.4 million for FY2024, which is 115.2% down from last year.
  • Latest data reveals that Guardant Health reported Depreciation & Amortization (CF) of $9.4 million as of Q3 2025, which was down 1122.85% from $10.0 million recorded in Q2 2025.
  • In the past 5 years, Guardant Health's Depreciation & Amortization (CF) registered a high of $11.0 million during Q3 2023, and its lowest value of $5.0 million during Q1 2021.
  • For the 5-year period, Guardant Health's Depreciation & Amortization (CF) averaged around $9.1 million, with its median value being $10.2 million (2022).
  • As far as peak fluctuations go, Guardant Health's Depreciation & Amortization (CF) surged by 7689.39% in 2022, and later plummeted by 1122.85% in 2025.
  • Over the past 5 years, Guardant Health's Depreciation & Amortization (CF) (Quarter) stood at $6.1 million in 2021, then surged by 66.98% to $10.2 million in 2022, then increased by 6.87% to $10.9 million in 2023, then dropped by 3.81% to $10.5 million in 2024, then fell by 10.01% to $9.4 million in 2025.
  • Its last three reported values are $9.4 million in Q3 2025, $10.0 million for Q2 2025, and $10.2 million during Q1 2025.